
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A biotech company in Cambridge seeks a Machine Learning Director to lead innovative ML strategies for antibody therapeutics. The ideal candidate will have a PhD in a relevant field and significant biopharmaceutical industry experience. Responsibilities include overseeing ML initiatives, collaborating with research teams, and communicating complex concepts. An exciting opportunity to contribute to groundbreaking work in drug discovery within a dynamic environment.
Alchemab has developed a highly differentiated platform that identifies novel drug targets and therapeutics through analysis of patient antibody repertoires. By combining well-defined patient samples, deep B cell sequencing, and computational analysis, the platform uncovers convergent protective antibody responses among individuals that are susceptible but resilient to specific diseases. Central to this approach are Alchemab’s pioneering antibody foundation models - including AntiBERTa and FAbCon - which are critical to the platform’s success.
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with an initial focus on neurodegeneration, immunology and oncology. The unique patient samples that power Alchemab’s platform are made available through valued partnerships and collaborations with patient representative groups, biobanks, industry partners, and academic institutions.
We are seeking an experienced Machine Learning (ML) Director who is passionate about applying machine learning to discover and develop transformative antibody therapeutics. This role is ideal for a scientific leader who combines strategic vision with a desire to stay deeply hands‑on – someone who thrives at the interface of research, innovation, and impact.
At Alchemab, ML is a highly collaborative discipline. You will work closely with software engineers, bioinformaticians, assay scientists and antibody engineers to drive the evolution of our platform and accelerate therapeutic discovery. This is a rare opportunity to build on Alchemab’s powerful foundations, including the world’s largest dataset of antibodies from disease‑resilient individuals and cutting‑edge multimodal and generative antibody foundation models, to push the limits of what’s possible in antibody discovery.
NOTE: This job description is not intended to be all inclusive. Employees may perform other related duties as negotiated to meet the ongoing needs of the organisation.
Note to recruitment agencies: we are not looking for assistance at this stage so please contact the HR department only at hr@alchemab.com if you think you can help in the future.